share_log

3M | 10-K: FY2023 Annual Report

3M | 10-K:2023财年年报

美股SEC公告 ·  2024/02/07 22:30

Moomoo AI 已提取核心信息

3M, a diversified global manufacturer and technology innovator, has made significant changes in its business operations and financial reporting. The company has restructured its Consumer business segment and updated its segment profit/loss measures. Additionally, 3M has adjusted certain non-GAAP measures for special items, reflecting these changes across all presented periods. The company operates across four business segments, with plans to spin off its Health Care business into a separate public entity by the first half of 2024, subject to regulatory approvals and final board consent. This strategic move is aimed at enhancing growth and shareholder value for both entities. Geographically, 3M reports organic sales changes, excluding the impact of foreign currency translation and acquisitions, to provide a clearer picture of its operational...Show More
3M, a diversified global manufacturer and technology innovator, has made significant changes in its business operations and financial reporting. The company has restructured its Consumer business segment and updated its segment profit/loss measures. Additionally, 3M has adjusted certain non-GAAP measures for special items, reflecting these changes across all presented periods. The company operates across four business segments, with plans to spin off its Health Care business into a separate public entity by the first half of 2024, subject to regulatory approvals and final board consent. This strategic move is aimed at enhancing growth and shareholder value for both entities. Geographically, 3M reports organic sales changes, excluding the impact of foreign currency translation and acquisitions, to provide a clearer picture of its operational performance. In 2023, 3M faced significant litigation costs totaling approximately $15.2 billion pre-tax, including charges related to the PWS and CAE Settlements. The company's financial statements for the year ended December 31, 2023, have been prepared in accordance with U.S. GAAP and reflect management's estimates where necessary. 3M maintains a robust internal control system over financial reporting, which has been deemed effective as of December 31, 2023, by PricewaterhouseCoopers LLP. The company's commitment to high ethical standards and continual internal audit reviews support the integrity of its financial reporting.
3M是一家多元化的全球制造商和科技创新者,已在其业务运营和财务报告方面进行了重大调整。该公司已经重组了其消费业务部门,并更新了部门利润/亏损指标。此外,3M对特殊项目的某些非公认会计准则(non-GAAP)指标进行了调整,反映了这些变化在所有报告期内的情况。公司运营于四个业务板块,并计划在2024年上半年将其医疗保健业务分拆为一个独立的上市实体,受监管批准和最终董事会同意的限制。这一战略举措旨在增强两个实体的增长和股东价值。从地域上看,3M报告有机销售变化,排除了外汇转换和收购的影响,以提供更清晰的运营表现图景。在2023年,3M面临重要的诉讼费用,总计约为152亿美元的税前费用,其中包括与P...展开全部
3M是一家多元化的全球制造商和科技创新者,已在其业务运营和财务报告方面进行了重大调整。该公司已经重组了其消费业务部门,并更新了部门利润/亏损指标。此外,3M对特殊项目的某些非公认会计准则(non-GAAP)指标进行了调整,反映了这些变化在所有报告期内的情况。公司运营于四个业务板块,并计划在2024年上半年将其医疗保健业务分拆为一个独立的上市实体,受监管批准和最终董事会同意的限制。这一战略举措旨在增强两个实体的增长和股东价值。从地域上看,3M报告有机销售变化,排除了外汇转换和收购的影响,以提供更清晰的运营表现图景。在2023年,3M面临重要的诉讼费用,总计约为152亿美元的税前费用,其中包括与PWS和CAE和解相关的费用。该公司截至2023年12月31日的财务报表已依照美国公认会计原则(U.S. GAAP)编制,并在必要时反映管理层的估算。3M在财务报告方面维持了强有力的内部控制系统,截至2023年12月31日被普华永道会计师事务所(PricewaterhouseCoopers LLP)认定为有效。公司对高伦理标准的承诺以及持续的内部审计审查支持其财务报告的完整性。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息